Cul4A is an oncogene in malignant pleural mesothelioma

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 2, 2011, Pages 350-358

  Hung, Ming Szu ^a,b,c   Mao, Jian Hua ^d   Xu, Zhidong ^a   Yang, Cheng Ta ^b,c   Yu, Jau Song ^c   Harvard, Chansonette ^e   Lin, Yu Ching ^b   Bravo, Dawn Therese ^a   Jablons, David M ^a   You, Liang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Amplification; Cul4A; Mesothelioma; P21; P27

Indexed keywords

CUL4A PROTEIN, HUMAN; CULLIN; CYCLINE; P27 ANTIGEN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE; GENETICS; HUMAN; MESOTHELIOMA; METABOLISM; ONCOGENE; PLEURA TUMOR; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CULLIN PROTEINS; HUMANS; MESOTHELIOMA; ONCOGENES; PLEURAL NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; RHO GTP-BINDING PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 79951936931     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00971.x     Document Type: Article

References (29)

1. Bueno R. Mesothelioma clinical presentation. Chest. 1999; 116: 444S-5S.
2. Nowak AK, Lake RA, Kindler HL, et al New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin Oncol. 2002; 29: 82-96.
3. Zhong W, Feng H, Santiago FE, et al CUL-4 ubiquitin ligase maintains genome stability by restraining DNA-replication licensing. Nature. 2003; 423: 885-9.
4. Higa LA, Wu M, Ye T, et al CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat Cell Biol. 2006; 8: 1277-83.
5. Osaka F, Kawasaki H, Aida N, et al A new NEDD8-ligating system for cullin-4A. Genes Dev. 1998; 12: 2263-8.
6. El-Mahdy MA, Zhu Q, Wang QE, et al Cullin 4A-mediated proteolysis of DDB2 protein at DNA damage sites regulates in vivo lesion recognition by XPC. J Biol Chem. 2006; 281: 13404-11.
7. Higa LA, Yang X, Zheng J, et al Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27Kip1 and cyclin E degradation. Cell Cycle. 2006; 5: 71-7.
8. Gupta A, Yang LX, Chen L. Study of the G2/M cell cycle checkpoint in irradiated mammary epithelial cells overexpressing Cul-4A gene. Int J Radiat Oncol Biol Phys. 2002; 52: 822-30.
9. Waning DL, Li B, Jia N, et al Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis. Blood. 2008; 112: 320-9.
10. Chen LC, Manjeshwar S, Lu Y, et al The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res. 1998; 58: 3677-83.
11. Yasui K, Arii S, Zhao C, et al TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology. 2002; 35: 1476-84.
12. Schindl M, Gnant M, Schoppmann SF, et al Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer Res. 2007; 27: 949-52.
13. Nishitani H, Shiomi Y, Iida H, et al CDK inhibitor p21 is degraded by a PCNA coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J Biol Chem. 2008; 283: 29045-52.
14. Li B, Jia N, Kapur R, et al Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis. Blood. 2006; 107: 4291-9.
15. Matsuda N, Azuma K, Saijo M, et al DDB2, the xeroderma pigmentosum group E gene product, is directly ubiquitylated by Cullin 4A-based ubiquitin ligase complex. DNA Repair. 2005; 4: 537-45.
16. Nag A, Bagchi S, Raychaudhuri P. Cul4A physically associates with MDM2 and participates in the proteolysis of p53. Cancer Res. 2004; 64: 8152-5.
17. Lee TC, Zhang Y, Aston C, et al Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules. Cancer Res. 1993; 53: 2858-64.
18. Bondar T, Kalinina A, Khair L, et al Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome. Mol Cell Biol. 2006; 26: 2531-9.
19. Yang CT, You L, Uematsu K, et al p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53. Cancer Res. 2001; 61: 5959-63.
20. Miranda-Carboni GA, Krum SA, Yee K, et al A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors. Genes Dev. 2008; 22: 3121-34.
21. Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 1995; 55: 5187-90.
22. Sekiguchi T, Hunter T. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells. Oncogene. 1998; 16: 369-80.
23. Loda M, Cukor B, Tam SW, et al Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 1997; 3: 231-4.
24. Porter PL, Malone KE, Heagerty PJ, et al Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med. 1997; 3: 222-5.
25. Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008; 8: 253-67.
26. Fero ML, Randel E, Gurley KE, et al The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature. 1998; 396: 177-80.
27. Coats S, Flanagan WM, Nourse J, et al Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science. 1996; 272: 877-80.
28. Polyak K, Lee MH, Erdjument-Bromage H, et al Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 1994; 78: 59-66.
29. Shirane M, Harumiya Y, Ishida N, et al Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem. 1999; 274: 13886-93.